Palobiofarma

Barcelona, Spain · Founded 2005 · Privately Held (backing)

Developer of adenosine receptor modulators designed to advance treatments for orphan and neurological diseases. Palobiofarma is based in Barcelona, Spain and was founded in 2005. Its last known valuation is $79.3 million. It has raised $21.1 million.

Last price · $/share

—

Implied valuation

$79.3M

Total raised

$21.1M

Last round

—

How much has Palobiofarma raised?

$21.1Macross 0 recorded rounds

Free account

More of Palobiofarma with a free account

·The complete investor list: 15 names
·Watch Palobiofarma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Palobiofarma investors

15 investors are on record for Palobiofarma, including European Union, INNVIERTE SICC, Inveready Asset Management and Sociedad de Desarrollo de Navarra.

For fundraisers

Raising for a company like Palobiofarma?

15 investors have backed Palobiofarma.

See all 15 investors →

Frequently asked about Palobiofarma

How much has Palobiofarma raised?: Palobiofarma has raised $21.1M in total across 0 recorded funding rounds.